Would you continue TNFi for inflammatory arthritis if the patient develops a solid organ malignancy while on that therapy?

Topics: Rheumatology • Rheumatoid Arthritis • Psoriatic arthritis • TNF Inhibitors • Solid organ malignancy • Malignancy • Dermatology

Answer from: at Academic Institution

In nearly all cases, I would stop the TNF inhibitor (TNFi). Though there is no evidence that these drugs raise the risk for solid organ tumor, the clinician must tread cautiously. First, the patient may require other potentially immune-suppressive anti-cancer therapies (plus radiation in some cases)...

Comments

at UTMB Health
Depending on the cancer in question, and the chemo...

at Montefiore Medical Center
How would you proceed with treatment post cancer t...

Related Questions